Hosted on MSN1y
Lonza to buy U.S. biologics site from Roche for $1.2B
Lonza (OTCPK:LZAGF ... capabilities to meet demand for the next generation of mammalian biologics therapies. The products currently manufactured at the site by Roche (OTCQX:RHHBY) (OTCQX:RHHBF ...
PharmiWeb2d
Lonza Implements its Simplified and Streamlined Operating Model
MiscellaneousLonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST Lonza’s new simplified and streamlined operating model is designed to support its One Lonza ...
pharmaphorum1y
Lonza adds biologics capacity with $1.2bn Roche deal
Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match ...
Seacoastonline.com22d
Lonza upgrades patio at Pease for employees
PORTSMOUTH — The Pease Development Authority’s Board of Directors voted to approve the concept plan for Lonza Biologics Inc., to install “canopy sunshades as an enhancement to the extended ...
The Scientist5mon
Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Under the terms of the new agreement, Lonza will manufacture the mAb at Lonza’s biologics facility in Porriño (ES), occupying a majority of the site’s manufacturing capacity. The ADC will then be ...
Hosted on MSN2mon
Lonza Posts Lower Sales, Earnings But Expects Capsules Business Rebound This Year
Lonza Group posted lower sales and earnings ... sales fell 2.1% to 6.57 billion Swiss francs ($7.27 billion) as growth in its biologics division couldn’t offset lower sales in its capsules ...